2002 Program Initiatives/Milestones
Oral UF Heparin: Completed multinational Phase III study
Oral LMW Heparin: Initiated Phase I testing
Oral Insulin: Completed 90-day toxicology studies
Oral Insulin: Initiated fed Type II patient study
Oral PTH: Completed first Phase I trial
Oral Cromolyn: Initiated preliminary patient studies in allergy patients